home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

"Know Your Customer" - The DEA Due Diligence - Webinar By GlobalCompliancePanel

 
  October 28, 2010  
     
 
GlobalCompliancePanel, Wilmington
2010-11-30


Overview: This training will cover several recommendations to improve Due Diligence when distributing Schedules II through V controlled substances and regulated chemicals to your customers and what steps can be taken to prevent the illicit use or diversion of any product sold to a customer.

As a firm handling these products, you will get a better understanding of what is required from a DEA registered Manufacturer or Distributor when a customer’s order becomes an order of interest or identified as a suspicious order.

Why should you attend: Understanding the DEA "Know Your Customer" Policy is important, and the steps suggested in this training will give you a better insight as to what steps should be taken to prevent the illicit use or diversion of any controlled substance and regulated chemical products purchased by a customer. What the presentation does is that it gives you a better understanding of what the suggested regulatory compliance should look like in order to identify those customer orders that should be classified as suspicious in nature and what actions they can take to prevent the diversion of their products by their customers.

Areas Covered in the Session:
  • DEA Office Of Diversion Control: This section will familiarize you with the authority given to the Diversion Group when enforcing the laws and regulations pertaining to controlled substances and regulated chemicals.
  • Due Diligence: This section provides some suggestions on improving the regulatory compliance of a firm handling Schedules II through V controlled substances and regulated chemical products.
  • DEA "know Your Customer" Policy: This section provides a better understanding of what DEA requires from a registrant in order to maintain an effective suspicious ordering process.
  • DEA Recordkeeping Requirements: This section covers the required records to be maintained in order to comply with the DEA regulations.
  • Customer Files Records: This section provides suggestions on what information should be in a Customer’s File in order to maintain an affection file, especially for a customer whose orders have been identified suspicious in nature.
Who Will Benefit: All corporate members and regulatory compliance and quality assurance personnel of a Manufacturer or Distributor registered with DEA to handle controlled substances and regulated chemical products.
 
 
Organized by: GlobalCompliancePanel
Invited Speakers: Carlos M. Aquino brings 36 years of experience on handling illicit and pharmaceutical controlled substances and regulated chemicals. His investigative experience and skills includes his testimonial ability both in federal and state courts. Calros Aquino has 12 years of experience working for Philadelphia DEA Diversion Group, including eight years as a diversion investigator and four years as a group supervisor. During his time at the DEA he performed numerous regulatory inspections of manufacturers, distributors, importers/exporters, physicians, researchers, and pharmacies in order to determine their compliance with the federal laws and DEA regulations pertaining to controlled substances in Schedules II through V and regulated chemicals. DEA Diversion is also responsible to initiate prosecutions of those DEA registrants who violate the federal Controlled Substances Act or DEA regulations pertaining to handling these substances. In addition to the above, Carlos has over 20 years of experience working for various laws enforcement agencies including the Philadelphia police. Carlos holds a bachelor in BA in Criminal Justice and has taught numerous courses during his time at the DEA.

He is skilled in interpreting the Controlled Substances Act (CSA) and the Code of Federal Regulations (CFR), assisting the pharmaceutical industry with compliance, and preparing and submitting Drug Enforcement Administration (DEA) Forms 41, 104, 106, 222, 236, 486.
 
Deadline for Abstracts: 2010-11-30
 
Registration:
Tuesday, November 30, 2010  
10:00 AM PDT | 01:00 PM EDT
Live live online training only for one participant
Price: $245.00
 
 
 
Corporate Live 4 to 10 participants from a single location (For multiple locations contact Customer Care)
Price: $995.00
 

Recorded Access recorded version only for one participant; unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
Price: $295.00
E-mail: webinars@GlobalCompliancePanel.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.